Endometriosis represents a frequently diagnosed gynecological affliction in the reproductive
timespan of women, defined by symptoms ranging from pelvic pain to infertility. A complex …

Only a few markers have been instrumental in the diagnosis of cancer. In contrast, tumor
markers play a critical role in the monitoring of patients. The patient's clinical status and …

Background: CA125 is a high molecular weight glycoprotein, which is expressed by a large
proportion of epithelial ovarian cancers. The sensitivity and specificity of CA125 are poor …

OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer.
This study measured the HE4 and CA125 levels in women with benign gynecological …

Background Ovarian cancer has a poor survival rate due to late diagnosis and improved
methods are needed for its early detection. Our primary objective was to identify and …

Abstract In June 1998, a Steering and Revisions Committee of the International Institute for
the Unification of Private Law (Unidroit) fleshed out the final version of a" Draft Unidroit …

Background Little is known about the correlations between tumor markers (TMs), breast
cancer subtypes, site (s) of metastasis and prognosis. Methods Women diagnosed with …

Ovarian cancer (OC) represents the most lethal gynecological cancer and the poor
prognosis is often attributable to late diagnosis. The diagnostic approach to woman …

Despite the relatively low prevalence, ovarian cancer is the fifth leading cause of death from
cancer among women. As such, an early diagnosis for establishing a timely surgical and/or …

OBJECTIVE: Cancer antigen 125 (CA 125) is a high molecular mass glycoprotein, usually
used for monitoring the course of epithelial ovarian cancer. Recently it has been shown that …